Interest

EQS-News: HomeToGo Releases 2024 Outlook: Strong Growth in IFRS Revenues of >35% YoY to €>220M Alongside Significant Adjusted EBITDA Growth. Share Tender Offering Announced

Retrieved on: 
Wednesday, April 10, 2024

HomeToGo Releases 2024 Outlook: Strong Growth in IFRS Revenues of >35% YoY to €>220M Alongside Significant Adjusted EBITDA Growth.

Key Points: 
  • HomeToGo Releases 2024 Outlook: Strong Growth in IFRS Revenues of >35% YoY to €>220M Alongside Significant Adjusted EBITDA Growth.
  • HomeToGo Releases 2024 Outlook: Strong Growth in IFRS Revenues of >35% YoY to €>220M Alongside Significant Adjusted EBITDA Growth.
  • Booking Revenues to grow to €>250M (>30% YoY) vs. €190.1M in FY/23
    IFRS Revenues to grow to €>220M (>35% YoY) vs. €162.0M in FY/23
    Adj.
  • EBITDA to grow to €>10M (>400% YoY) vs. €1.8M in FY/23
    Booking Revenues of €190.1M for FY/23 (16% YoY), surpassing FY/23 financial guidance.

EQS-News: Brockhaus Technologies AG: Dynamic and highly profitable growth continues in 2024 and 2025

Retrieved on: 
Wednesday, April 10, 2024

At €186.6 million (2022: €142.7 million) revenue in the 2023 financial year was up by +31% compared to the previous year.

Key Points: 
  • At €186.6 million (2022: €142.7 million) revenue in the 2023 financial year was up by +31% compared to the previous year.
  • Brockhaus Technologies achieved an adjusted EBITDA margin of 33.3% (2022: 33.2%) and an adjusted EBIT margin of 30.9% (2022: 30.9%).
  • In the interest of an attractive dividend policy, Brockhaus Technologies aims to distribute a steadily increasing dividend in the future.
  • Brockhaus Technologies continues to have a high balance sheet quality and a very solid financing structure.

EQS-News: STRABAG SE: Implementation of non-cash capital increase entered in the commercial register; details on issuance of new shares and cash distribution

Retrieved on: 
Wednesday, April 10, 2024

STRABAG SE: Implementation of non-cash capital increase entered in the commercial register; details on issuance of new shares and cash distribution

Key Points: 
  • STRABAG SE: Implementation of non-cash capital increase entered in the commercial register; details on issuance of new shares and cash distribution
    The issuer is solely responsible for the content of this announcement.
  • The implementation of the ordinary non-cash capital increase was registered in the commercial register by the Klagenfurt Regional Court as planned on 21/03/2024.
  • The 15,621,982 new shares from the capital increase will be issued on 26/03/2024 to the holders of existing STRABAG shares under ISIN AT0000A36HH9 (STRABAG SE – Distribution Share-Based Option).
  • The distribution of the securities for receipt of the cash distribution of the capital reduction amount (ISIN AT0000A36HK3) to the holders of existing STRABAG shares with ISIN AT000000STR1 will also occur on 26/03/2024.

EQS-News: USU Offers Starter Pack for Professional IT Service Management

Retrieved on: 
Wednesday, April 10, 2024

Implementing and operating a robust IT Service Management (ITSM) system doesn't have to be lengthy or expensive.

Key Points: 
  • Implementing and operating a robust IT Service Management (ITSM) system doesn't have to be lengthy or expensive.
  • USU is now offering the ITSM Starter Pack for a swift entry into professional IT Service Management.
  • The starter pack includes consultation and training, along with the setup of USU Service Management with modules for Incident & Service Request, Ticketing, User Management, and an Interface Tool within a SaaS environment, all at an attractive fixed price.
  • A pragmatic, step-by-step approach, starting with an ITSM starter package, enables quick wins and lays the foundation for a digital future," emphasizes Achim Rudolph, Senior Vice President of USU.

Xediton Pharmaceuticals Inc. To Present at The 2024 Bloom Burton & Co. Healthcare Investor Conference

Retrieved on: 
Tuesday, April 9, 2024

President & CEO, George Gafrey will be speaking at 11:00 AM ET on April 17th.

Key Points: 
  • President & CEO, George Gafrey will be speaking at 11:00 AM ET on April 17th.
  • Interested parties can register to attend here .
  • Members of the Xediton Pharmaceuticals Inc. management team will also be taking meetings throughout the day.
  • To register for the 2024 Bloom Burton & Co. Healthcare Investor Conference, please follow this link .

SRx Health Solutions Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Retrieved on: 
Tuesday, April 9, 2024

Adesh Vora, President and CEO, and Dr. Hemant Shah, Chief Medical Officer, will be speaking at 10:30AM ET on April 17th.

Key Points: 
  • Adesh Vora, President and CEO, and Dr. Hemant Shah, Chief Medical Officer, will be speaking at 10:30AM ET on April 17th.
  • Interested parties can register to attend here .
  • Members of the SRx Health Solutions Inc. management team will also be taking meetings throughout the day.
  • To register for the 2024 Bloom Burton & Co. Healthcare Investor Conference, please follow this link .

CatsCoin (CATSS) Is Now Available for Trading on LBank Exchange

Retrieved on: 
Friday, April 5, 2024

Road Town, British Virgin Islands--(Newsfile Corp. - April 5, 2024) - In a significant move for cryptocurrency and mobile technology enthusiasts, LBank Exchange, a premier global digital asset trading platform, has announced the listing of CatsCoin (CATSS) on April 3, 2024.

Key Points: 
  • Road Town, British Virgin Islands--(Newsfile Corp. - April 5, 2024) - In a significant move for cryptocurrency and mobile technology enthusiasts, LBank Exchange, a premier global digital asset trading platform, has announced the listing of CatsCoin (CATSS) on April 3, 2024.
  • Users of LBank Exchange can brace themselves for the CATSS/USDT trading pair, which went live already.
  • The core vision behind CatsCoin is to orchestrate a feline revolution in the memecoin market, challenging the long-standing dominance of dog-themed cryptocurrencies.
  • Acquiring CatsCoin is designed to be a straightforward process, encouraging adoption by leveraging decentralized finance (DeFi) platforms for ease of transaction.

Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Retrieved on: 
Wednesday, April 3, 2024

CEO Craig Mull and CFO Bryan Jacobs will be speaking at 2:30PM ET on April 17th.

Key Points: 
  • CEO Craig Mull and CFO Bryan Jacobs will be speaking at 2:30PM ET on April 17th.
  • Interested parties can register to attend here .
  • Members of the Cipher Pharmaceuticals management team will also be taking meetings throughout the day.
  • To register for the 2024 Bloom Burton & Co. Healthcare Investor Conference, please follow this link .

Andcards Announces Rebranding: Spacebring Aims to Reshape the Shared and Coworking Spaces with Innovative Technology

Retrieved on: 
Thursday, March 28, 2024

"Our transition to Spacebring signifies our dedication to empowering shared spaces beyond conventional boundaries," remarks Igor Dzhebyan, CEO and co-founder of Spacebring.

Key Points: 
  • "Our transition to Spacebring signifies our dedication to empowering shared spaces beyond conventional boundaries," remarks Igor Dzhebyan, CEO and co-founder of Spacebring.
  • "The customer support team at Spacebring is dedicated to helping owners make the most out of the platform and ensuring smooth operations for their shared space."
  • By choosing Spacebring, shared and coworking spaces can streamline administrative processes and boost community engagement for those using their space.
  • With its user-friendly interface, advanced features, and seamless integration capabilities, Spacebring presents a solution for managing shared spaces of any size.

Pharmascience Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Retrieved on: 
Wednesday, April 3, 2024

Montreal, Quebec--(Newsfile Corp. - April 3, 2024) - Pharmascience Inc., the largest Canadian-owned pharmaceutical company and a leader in the Canadian generic market, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre.

Key Points: 
  • Montreal, Quebec--(Newsfile Corp. - April 3, 2024) - Pharmascience Inc., the largest Canadian-owned pharmaceutical company and a leader in the Canadian generic market, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre.
  • Martin Arès, CEO will be speaking at 9:30am ET on April 17th.
  • Members of the Pharmascience Inc. management team will also be taking meetings throughout the day.
  • To register for the 2024 Bloom Burton & Co. Healthcare Investor Conference, please follow this link .